Mastitis is one of the most economically devastating diseases of dairy cattle particularly for the back yard farmers in developing world, with different levels of economic losses reported by different countries. More than $130 million is lost by the Australian dairy industry ($A200/cow/year) every year due to poor udder health resulting in reduced milk production that is mainly associated with mastitis. A herd without an effective mastitis control programme may witness morbidity as high as 40% with infection, on an average of two quarters of the mammary gland. Of the various clinical manifestations, subclinical mastitis is economically the most important due to its long term effects on milk yields. Huge economic losses are also incurred due to unmarketable milk or milk-products contaminated with antibiotic residues originating from treatment in the developing nations as well as from the use of antibiotics as growth promoters particularly in dairy feedlots in the developed world. The prolonged use of antibiotics in the treatment of mastitis has led to the additional problem of emergence antibiotic resistant strains, hence the constant concern about the resistant strains entering the food chain. Many organisms associated with mastitis also have zoonotic importance and can cause diseases like brucellosis, tuberculosis, leptospirosis, Q-fever etc.
Trends In Therapeutic and Prevention Strategies for Management of Bovine Mastitis: An Overview: JullyGogoi Tiwari, Charlene Babra, Harish Kumar Tiwari, Vincent Williams, Sharon De Wet, Justine Gibson, Adrian Paxman, Eleanor Morgan, Paul Costantino, Raju Sunagar, Shrikrishna Isloor and Trilochan Mukkur
Last date updated on October, 2020